Collaborations
Bright Minds engages with the broader scientific community to amplify our understanding of the biology and mechanism of action of mental and neurological disorders.
National Institutes of Health
Washington DC
Bright Minds is partnered with the NIH in two separate programs. One evaluating our compounds for the treatment of epilepsy. The other, assessing treatment for non-opioid pain management.
Acceptance into both programs is a strong validation for Bright Minds’ approach and existing data. This collaboration is an example of Bright Minds non-dilutive approach as associated costs are fully covered by the NIH.
University Of Texas Medical Branch
Cunningham Lab
Galveston, Texas
Led by Dr. Kathryn Cunningham PhD, the Cunningham Lab is a leader in the evaluation and development of therapeutics focused on addiction treatment and impulse control disorders such as binge eating.
Medical College of Wisconsin
McCorvy Lab
Milwaukee, Wisconsin
Led by Dr John McCorvy PhD, the McCorvy Lab is renown for its groundbreaking work on biological understanding of psychedelics and related compounds including the serotonergic system.
Katholieke Universiteit Leuven
DeWitte Lab
Leuven, Belgium
Led by Dr. Peter DeWitte PhD, the DeWitte Lab has been instrumental in furthering biological understanding of various epilepsy disorders including rare pediatric disorders such as Dravet Syndrome and Lennox-Gastaut Syndrome.
